Related Experiment Video
Updated: Apr 23, 2026

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
Published on: August 13, 2017
Interplay between sumoylation and phosphorylation for protection against α-synuclein inclusions
Hedieh Shahpasandzadeh1, Blagovesta Popova1, Alexandra Kleinknecht1
1From the Institute of Microbiology and Genetics, Department of Molecular Microbiology and Genetics, Georg-August-Universität Göttingen, D-37077 Göttingen, Germany, the Center for Nanoscale Microscopy and Molecular Physiology of the Brain, D-37073 Göttingen, Germany.
Sumoylation of alpha-synuclein protects against Parkinson disease pathology by aiding aggregate clearance. Phosphorylation can compensate for sumoylation defects, promoting clearance via autophagy and proteasomal pathways.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Parkinson disease involves dopaminergic neuron loss and Lewy body formation, primarily of alpha-synuclein.
- Alpha-synuclein undergoes post-translational modifications like phosphorylation and sumoylation, crucial for its function and aggregation.
- The interplay between alpha-synuclein sumoylation and phosphorylation in Parkinson disease pathogenesis remains unclear.
Purpose of the Study:
- To investigate the interplay between alpha-synuclein sumoylation and phosphorylation.
- To determine the impact of these modifications on cell growth and inclusion formation in a yeast model.
- To explore potential therapeutic strategies targeting these modifications for Parkinson disease.
Main Methods:
- Utilized a yeast model to study alpha-synuclein modifications in vivo.
- Assessed the effects of impaired sumoylation and phosphorylation on yeast growth and inclusion formation.
- Investigated the roles of autophagy and proteasomal degradation in aggregate clearance.
Main Results:
- Alpha-synuclein sumoylation occurs at conserved sites in yeast, similar to human cells.
- Impaired sumoylation led to reduced yeast growth and increased alpha-synuclein inclusions, indicating a protective role for sumoylation.
- Inhibition of sumoylation blocked autophagy-mediated aggregate clearance.
- Serine 129 phosphorylation by GRK5 suppressed sumoylation defects, reduced inclusions, and promoted aggregate clearance via both autophagy and proteasomal pathways.
Conclusions:
- Sumoylation plays a protective role in preventing alpha-synuclein aggregation and promoting its clearance.
- Phosphorylation can counteract the negative effects of sumoylation deficiency, facilitating aggregate clearance.
- The findings highlight a complex interplay between sumoylation and phosphorylation in alpha-synuclein aggregate clearance, offering potential therapeutic targets for Parkinson disease.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Parkinson Disease ll: Pathophysiology
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

